Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Gastroduodenal lesions are a common complication in patients with
liver cirrhosis
. The etiology of this problem has been investigated from the standpoint of both mucosal protective factors and aggressive factors. Among the various mucosal protective factors, much emphasis has been placed on the disturbance of microcirculation in the gastric mucosa as a result of stasis in the portal vein.
Duodenogastric reflux
may be involved in the etiology of the gastric mucosal changes. And, Phospholipids levels in the gastric mucosa were reduced in
cirrhosis
. Regarding aggressive factors, there have been many reports of diminished secretion of gastric acid. But, patients with ulcer had a tendency to be higher gastric acidity than those without ulcer. Drugs increased mucosal defense might be effective in healing gastroduodenal lesions in
cirrhosis
. Despite the observation that acid secretion decreased in
cirrhosis
, inhibition of acid secretion induces ulcer healing. In
cirrhosis
, a high incidence of gastric cancer was reported, so that patients should be undergo periodic screening with endoscopy.
...
PMID:[Gastroduodenal lesions in patients with liver cirrhosis--pathogenesis and management]. 811 17